I am the Lecturer, Dr. Abeer Muhammad Hussein. I completed my bachelor’s degree from the Biology Department, College of Science for Women / University of Baghdad in the year 2004 - 2005. Then I was appointed to the same college and completed my master’s studies in the same department in the specialty of animal physiology in the year 2011 - 2012. .. After that, I completed my doctorate in the same department also in the year 2019-2020, and it was a study on some physiological parameters related to Iraqi women with breast cancer...
Biology PhD
Examination Committee for Preliminary Studies
Examination Committee for Preliminary Studies
Human Physiology Histiology Cancer Haematology
Baghdad University College of Science for Women Biology Department
Animal Physiology Histology
Master Student Undergrauadte Student
Breast cancer is the most prevalent malignancy among women worldwide, in Iraq it ranks the first among the population and the leading cause of cancer related female mortality. This study is designed to investigate the correlations between serum and tissue markers in order to clarify their role in progression or regression breast cancer. Tumor Markers are groups of substances, mainly proteins, produced from cancer cell or from other cells in the body in response to tumor. The study was carried out from April 2018 to April 2019 with total number of 60 breast cancer women. The blood samples were collected from breast cancer women in postoperative and pretherapeutic who attended teaching oncology hospital of the medical city in Baghdad and
... Show More
(4)
(1)
The prospective study has been designed to determine some biomarkers in Iraqi female patients with
breast cancer. The current study contained 30 patients whose tissue samples have been collected from
hospitals in Medical City in Baghdad after consent patients themselves and used immunohistochemical
technique to determine these markers. The results showed a significant correlation between ER and PR tissue
markers (Sig = 0.000) and a significant correlation between cyclin E phenotype and cyclin E intensity (Sig =
0.001).
(4)
(1)